We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIOS
6551
DELISTED
BioPlus Acquisition Corp. Class A Ordinary Shares
BIOS
– –
-92
Closed -$1K
MCLD
6552
DELISTED
mCloud Technologies Corp. Common Shares
MCLD
– –
-100
Closed –
OTMOW
6553
DELISTED
Otonomo Technologies Ltd. Warrant
OTMOW
$0 ﹤0.01%
35
– –
LMNL
6554
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
– –
-40
Closed –
FATH.WS
6555
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
$0 ﹤0.01%
100
– –
BRDS.WS
6556
DELISTED
Bird Global, Inc. Warrants each whole warrant exercisable to purchase 1/25th of a share of Class A Common Stock at an exercise price of $287.50 per share
BRDS.WS
$0 ﹤0.01%
100
– –
ZEV.WS
6557
DELISTED
Lightning eMotors, Inc. Redeemable Warrants, each whole warrant exercisable 1/20th of a share of common stock at an exercise price of $230.00 per whole share
ZEV.WS
$0 ﹤0.01%
109
– –
NSTD.U
6558
DELISTED
Northern Star Investment Corp. IV Units, each consisting of one share of Class A common stock and one-sixth of one redeemable warrant
NSTD.U
$0 ﹤0.01%
7
– –
SURF
6559
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$0 ﹤0.01%
91
-4,200
-98% -$3.4K
ROIVW
6560
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$0 ﹤0.01%
126
– –
CCAI
6561
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
– –
-16
Closed –
SABRP
6562
DELISTED
Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock
SABRP
$0 ﹤0.01%
+4
New +$320
FXCOW
6563
DELISTED
Financial Strategies Acquisition Corp. Warrants
FXCOW
$0 ﹤0.01%
100
– –
GFX.U
6564
DELISTED
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
$0 ﹤0.01%
1
– –
APGNW
6565
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$0 ﹤0.01%
58
– –
HMACU
6566
DELISTED
Hainan Manaslu Acquisition Corp. Unit
HMACU
– –
-100
Closed -$1K
OXACU
6567
DELISTED
Oxbridge Acquisition Corp. Unit
OXACU
$0 ﹤0.01%
29
– –
BWC
6568
DELISTED
Blue Whale Acquisition Corp I Class A Ordinary Shares
BWC
– –
-49
Closed –
EGIS
6569
DELISTED
2ndVote Society Defended ETF
EGIS
– –
-25,627
Closed -$838K
LYFE
6570
DELISTED
2ndVote Life Neutral Plus ETF
LYFE
– –
-10,520
Closed -$305K
EMBKW
6571
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$0 ﹤0.01%
111
– –
SPPI
6572
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$0 ﹤0.01%
50
-11,648
-100% -$8.5K
QFTA.U
6573
DELISTED
Quantum FinTech Acquisition Corporation Units, each consisting of one share of Common Stock and one Warrant
QFTA.U
$0 ﹤0.01%
20
– –
TLGA.U
6574
DELISTED
TLG Acquisition One Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TLGA.U
$0 ﹤0.01%
46
– –
GGAA
6575
DELISTED
Genesis Growth Tech Acquisition Corp. Class A Ordinary Shares
GGAA
– –
-259
Closed -$3K
261 262
263
264 265

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.